Vascular Pharmacology

3.2(top 10%)

impact factor

1.8K(top 10%)

papers

45.5K(top 10%)

citations

90(top 5%)

h-index

3.2(top 20%)

impact factor

2.9K

all documents

47.8K

doc citations

138(top 5%)

g-index

Top Articles

#	Title	Journal	Year	Citations
1	Tight junctions of the blood–brain barrier	Vascular Pharmacology	2002	980
2	Oxidative stress and reactive oxygen species in endothelial dysfunction associated with cardiovascular and metabolic diseases	Vascular Pharmacology	2018	805
3	The role of oxidative stress, antioxidants and vascular inflammation in cardiovascular disease (a review)	Vascular Pharmacology	2015	707
4	Alterations of intracellular calcium concentration and nitric oxide generation in pulmonary artery endothelium after subarachnoid hemorrhage of the rabbit	Vascular Pharmacology	2007	521
5	Rho GTPases and the regulation of endothelial permeability	Vascular Pharmacology	2002	428
6	Arterial stiffness, atherosclerosis and cardiovascular risk: Pathophysiologic mechanisms and emerging clinical indications	Vascular Pharmacology	2016	338
7	Regulation of vascular permeability by vascular endothelial growth factors	Vascular Pharmacology	2002	308
8	The critical role of Akt in cardiovascular function	Vascular Pharmacology	2015	299
9	Angiogenesis—a new target for future therapy	Vascular Pharmacology	2006	277
10	Role of Ca2+ signaling in the regulation of endothelial permeability	Vascular Pharmacology	2002	257
11	Vascular endothelin in hypertension	Vascular Pharmacology	2005	239
12	From excess adiposity to insulin resistance: The role of free fatty acids	Vascular Pharmacology	2012	238
13	Protein kinase signaling in the modulation of microvascular permeability	Vascular Pharmacology	2002	215
14	Exosomes and exosomal miRNAs in cardiovascular protection and repair	Vascular Pharmacology	2015	211
15	Foam cell formation: A new target for fighting atherosclerosis and cardiovascular disease	Vascular Pharmacology	2019	207
16	Nitric oxide and the endothelium: History and impact on cardiovascular disease	Vascular Pharmacology	2006	206
17	LXRs;	Vascular Pharmacology	2002	205
18	Targeting NADPH oxidases in vascular pharmacology	Vascular Pharmacology	2012	204
19	Endothelial nitric oxide (NO) and its pathophysiologic regulation	Vascular Pharmacology	2008	199
20	Physiology and pathophysiology of oxLDL uptake by vascular wall cells in atherosclerosis	Vascular Pharmacology	2016	194
21	Drug transport to the brain: key roles for the efflux pump P-glycoprotein in the blood–brain barrier	Vascular Pharmacology	2002	191
22	Cardiovascular effects of DPP-4 inhibition: Beyond GLP-1	Vascular Pharmacology	2011	189
23	Pharmacological preconditioning with sildenafil: Basic mechanisms and clinical implications	Vascular Pharmacology	2005	184
24	Endothelial pathomechanisms in acute lung injury	Vascular Pharmacology	2008	183
25	Molecular mechanisms in the pathogenesis of diabetic nephropathy: An update	Vascular Pharmacology	2013	180
26	The innate immune system, toll-like receptors and dermal wound healing: A review	Vascular Pharmacology	2015	169
27	MicroRNA regulation in angiogenesis	Vascular Pharmacology	2011	155
28	The 6-min walk test (6MW) as an efficacy endpoint in pulmonary arterial hypertension clinical trials: Demonstration of a ceiling effect	Vascular Pharmacology	2005	152
29	HO-1/CO system in tumor growth, angiogenesis and metabolism — Targeting HO-1 as an anti-tumor therapy	Vascular Pharmacology	2015	148
30	Matrix metalloproteinase inhibition therapy for vascular diseases	Vascular Pharmacology	2012	146
31	Multiple paracrine factors secreted by mesenchymal stem cells contribute to angiogenesis	Vascular Pharmacology	2014	144
32	Drug delivery to brain via the blood–brain barrier	Vascular Pharmacology	2002	143
33	Immunomodulatory role of Withania somnifera root powder on experimental induced inflammation: An in vivo and in vitro study	Vascular Pharmacology	2006	142
34	Propranolol suppresses angiogenesis in vitro: Inhibition of proliferation, migration, and differentiation of endothelial cells	Vascular Pharmacology	2010	142
35	Effect of estrogen on endothelial function and angiogenesis	Vascular Pharmacology	2002	141
36	Estrogen and vascular function	Vascular Pharmacology	2002	139
37	Acute DPP-4 inhibition modulates vascular tone through GLP-1 independent pathways	Vascular Pharmacology	2011	137
38	Mesenchymal stem cell therapy for heart disease	Vascular Pharmacology	2012	137
39	Targets for pharmacological intervention of endothelial hyperpermeability and barrier function	Vascular Pharmacology	2002	136
40	Cellular and molecular mechanisms of vascular injury in diabetes — Part I: Pathways of vascular disease in diabetes	Vascular Pharmacology	2011	136
41	The G protein-coupled estrogen receptor GPER/GPR30 as a regulator of cardiovascular function	Vascular Pharmacology	2011	135
42	The diverse ligand repertoire of the receptor for advanced glycation endproducts and pathways to the complications of diabetes	Vascular Pharmacology	2012	134
43	Peroxisome proliferator-activated receptors in vascular biology-molecular mechanisms and clinical implications	Vascular Pharmacology	2006	133
44	LncRNAs in vascular biology and disease	Vascular Pharmacology	2019	133
45	The emerging challenge in diabetes: The “metabolic memory”	Vascular Pharmacology	2012	132
46	The first 3500 years of aspirin history from its roots – A concise summary	Vascular Pharmacology	2019	132
47	Endothelial injury in the initiation and progression of vascular disorders	Vascular Pharmacology	2007	130
48	Phytochemicals and their impact on adipose tissue inflammation and diabetes	Vascular Pharmacology	2013	130
49	Cardiovascular effects of ginger aqueous extract and its phenolic constituents are mediated through multiple pathways	Vascular Pharmacology	2005	129
50	Regulation and function of endothelial glycocalyx layer in vascular diseases	Vascular Pharmacology	2018	128

Scientometrics

Overviews

Citing Bodies

Vascular Pharmacology

Top Articles